Market Brief

The articles are produced in Chinese only.

Author

王富榮先生 (Chris Wong)
助理經理

現任職輝立助理經理,對投資大中小型股票均經驗豐富,亦擅於以窩輪、牛熊證操作。本人樂意為客戶提供投資分析及買賣策略。歡迎各位來電交流心得
Phone:
3925 9299

中國人壽 (02628.HK)

Thursday, November 6, 2025 Views215

中國人壽 02628.HK   受惠 A 股牛市

中國人壽 02628.HK 今年九個月淨利潤1678億元人民幣增長60.5%,較去年同期增長60.5%,基本每股收益5.94元。

第三季歸屬於母公司股東的淨利潤1268.73億元,增長91.5%。

 

公司在同業之間擁有最高盈利增長,今年首九個月增長60.5%,意味著第三季及首九個月的年度ROE分別為88.3%及39.4%。

公司首九個月的新業務價值增長加快至41.8%,而相較上半年則為20.3%。

 

另外公司顯著受惠 A 股市場升勢。首三季總投資回報率達6.4%,為同業最高,高於其他領先壽險公司的5.5%至5.8%。

 

如 A 股走勢於下年持續,預計中國人壽 02628.HK 走勢將保持不俗。

 

買賣策略

收集 $20-21  目標 $28   止蝕 $18

本人王富榮為證監會持牌人士。截至本評論文章發表日止,本人及/或其有聯繫者並無持有全部提及之證券的所有相關財務權益。

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on http://www.phillip.com.hk. Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email : businessenquiry@phillip.com.hk

Enquiry & Support
Branches
The Complaint Procedures
About Us
Phillip Securities Group
Join Us
Phillip Network
Phillip Post
Phillip Channel
Latest Promotion
新闻稿
E-Check
Login
Investor Notes
Free Subscribe
Contact Us